Meredith Mazzotta
By
Meredith Mazzotta
Published: July 23, 2012, 10:29 p.m.·
Tags:
None
Treatment Action Group’s leader Mark Harrington did not mince words Saturday at a consultation meeting on HIV and tuberculosis (TB) co-infection preceding the 2012 International AIDS Conference in Washington.
Read More →
By
Meredith Mazzotta
Published: July 23, 2012, 10:23 p.m.·
Tags:
None
We often cite the fact that tuberculosis (TB) fueled the spread of HIV in southern Africa, said Diane Havlir, MD, of the University of California at San Francisco and co-Chair of the 2012 International AIDS Conference (IAC). But AIDS also shaped the enormous spread of TB seen in southern Africa during the late 80s and ’90s as a sweeping increase in HIV/AIDS occurred simultaneously, she said.
Read More →
By
Meredith Mazzotta
Published: May 17, 2012, 9:34 p.m.·
Tags:
None
As of the end of the first quarter of 2012, nearly 864,000 GeneXpert MTB/RIF rapid tuberculosis (TB) diagnostic cartridges had been procured under manufacturer Cephied’s concessional pricing mechanism.
Read More →
By
Meredith Mazzotta
Published: May 16, 2012, 8:44 a.m.·
Tags:
None
UNITAID is inviting letters of intent (LOI), or short conceptual presentations of a proposed project, on the topic of improving access to key preventive, diagnostic and treatment commodities for HIV, tuberculosis (TB) and malaria through market-based approaches. UNITAID works to negotiate low pricing for diagnostics and medication for AIDS, tuberculosis and malaria in developing countries and is funded primarily by an airline levy in participating countries.
Read More →
By
Meredith Mazzotta
Published: April 5, 2012, 10:19 p.m.·
Tags:
None
Read More →
By
Meredith Mazzotta
Published: April 2, 2012, 10:10 p.m.·
Tags:
None
Former tuberculosis (TB) patients from around the world offered a unique glimpse at the impact of the disease on individuals, and the toll it takes on family and friends, by telling their personal stories at an event hosted by The U.S. Agency for International Development (USAID) in late March to honor World TB Day.
Read More →
By
Meredith Mazzotta
Published: March 22, 2012, 7:35 p.m.·
Tags:
None
Otsuka Pharmaceutical is the top private funder of tuberculosis (TB) research and drug development in the world. Last year, Otsuka established a Geneva-based subsidiary – Otsuka SA – to serve as “the company’s central operations for developing and implementing public health policies and corporate social responsibility programs in connection with its global TB program,” according to the company’s website.
Read More →
By
Meredith Mazzotta
Published: March 22, 2012, 5:27 p.m.·
Tags:
None
Read More →
By
Meredith Mazzotta
Published: March 20, 2012, 10:11 p.m.·
Tags:
None
In advance of World TB Day (Saturday, March 24) Science Speaks sat down with tuberculosis (TB) expert Lee B. Reichman, MD, MPH, founding executive director of the New Jersey Medical School Global Tuberculosis Institute, to discuss the spread of drug-resistant TB and what he thinks are the most promising advances coming down the scientific pipeline. Dr. Reichman has published more than 200 articles, scientific reviews and book chapters focusing on the diagnosis, treatment, prevention, control, regimen adherence and epidemiology of and advocacy for TB. He also co-authored the book Timebomb: The Global Epidemic of Multidrug-Resistant Tuberculosis with Janice Hopkins Tanne in 2002.
Read More →
By
Meredith Mazzotta
Published: March 9, 2012, 10:58 a.m.·
Tags:
None
At the 19th Conference on Retroviruses and Opportunistic Infections in Seattle, Dr. Helen Ayles presented some key results on behalf of the ZAMSTAR team from the first randomized trial of a combined HIV and TB intervention strategy to demonstrate a reduction in population prevalence of tuberculosis.
Read More →
Page 1 of 2 · Total posts: 10
1
2
Last→